Evidence map›Paper›PMID 31687427›Full record

ArticleData in brief2019

Proteomic dataset: Profiling of membrane fraction of

Olga Bukato, Olga Pobeguts, Daria Rakitina, Julia Baikova, Ivan Butenko, Artemy Silantyev, Gleb Fisunov, Vadim Govorun

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Data in brief, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Role of adherent invasiveWorld journal of clinical cases · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Olga BukatoFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russian Federation.
Olga PobegutsFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russian Federation.
Daria RakitinaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russian Federation.
Julia BaikovaFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russian Federation.
Ivan ButenkoFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russian Federation.
Artemy SilantyevV. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology National Scientific Research Centre on Addictions, Russian Federation.
Gleb FisunovFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russian Federation.
Vadim GovorunFederal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russian Federation.
Federal Medical-Biological Agency · RUFederal Medical Research Centre for Psychiatry and Narcology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) is a type of inflammatory bowel disease (IDB). The endoscopic picture of Crohn's disease includes thickened submucosa, transmural inflammation, fissuring ulceration, and non-caseating granulomas. Intestinal microbiome dysbiosis has been described systematically in patients with IBD. In recent decades it was detailed that

Indexed as

AIECCrohn's diseaseEscherichia coliLC-MS/MSMembrane proteinsProteome

Identifiers

PMID31687427
PMCPMC6820108
OpenAlexW2969797560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.